Effect of Individualized Occupational Therapy on Rehospitalization Among Patients With Schizophrenia: A Two-Year Follow-Up of a Randomized Controlled Trial
- PMID: 40385771
- PMCID: PMC12085067
- DOI: 10.7759/cureus.82429
Effect of Individualized Occupational Therapy on Rehospitalization Among Patients With Schizophrenia: A Two-Year Follow-Up of a Randomized Controlled Trial
Abstract
Background Schizophrenia is characterized by frequent rehospitalization. We developed an individualized occupational therapy (IOT) program to facilitate proactive participation in treatment and improve outcomes. We evaluated whether the addition of IOT to group occupational therapy (GOT) as usual care, compared to GOT alone, during hospitalization would lead to a reduction in the rehospitalization risk of schizophrenia. Methodology We conducted a 2-year prospective cohort study following a randomized controlled trial comparing GOT+IOT and GOT-alone groups. Participants were schizophrenia patients discharged within 1 year from psychiatric hospitals across Japan. We utilized the Brief Assessment of Cognition in Schizophrenia (BACS), Quality of Life Scale (QLS), European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L), Life Assessment Scale for the Mentally Ill (LASMI), Positive and Negative Syndrome Scale (PANSS), and modified Global Assessment of Functioning for Functioning (mGAF-F) at baseline, post-treatment, and 1 and 2 years after the index discharge. We comparatively analyzed the changes in each assessment from baseline to follow-up between groups using generalized linear mixed models. We used log-rank tests to compare the distribution of time to rehospitalization and plotted the Kaplan-Meier survival estimates for time to rehospitalization by group. We estimated hazard ratios (HRs) using Cox proportional hazards models to evaluate the impact of clinical factors on rehospitalization. We used Cox regression analyses to investigate the impact of each IOT component on rehospitalization. We conducted mediation analyses to evaluate the relationship between inpatient OT type and rehospitalization and the indirect effect of medication adherence on the relationship between inpatient OT type and rehospitalization. Results Among 66 who met the criteria, 34 were in GOT+IOT and 32 were in GOT-alone groups. Compared to GOT alone, GOT+IOT resulted in significant improvements in changes from baseline to 1 and 2 years in BACS, QLS, EQ-5D-5L, LASMI, PANSS, and mGAF-F. Overall rehospitalization rate was 43.55%; the GOT+IOT group showed a significantly lower rate with four rehospitalized compared to 23 in the GOT-alone group. Time to rehospitalization was significantly longer for GOT+IOT than for GOT alone. The Cox proportional hazards model showed that OT type (HR=0.03), resident support persons (HR=0.32), and medication adherence (HR=0.33) were significantly associated with rehospitalization. The univariate and multivariate Cox regression analyses on the impact of IOT components on rehospitalization revealed no significant components. The inpatient OT type had a significant total effect on rehospitalization (β=0.72). The direct effect of inpatient OT type on rehospitalization was significant (β=0.64), and the indirect effect of inpatient OT type on rehospitalization via medication adherence was not significant (β=0.08). Conclusions Adding IOT to standard care significantly prolonged time to rehospitalization, and receiving IOT during hospitalization reduced the risk of rehospitalization for schizophrenia. Significant factors related to each IOT component that affected rehospitalization were not detected. IOT reduces the risk of rehospitalization via improved medication adherence and has a strong effect as IOT itself reduces the risk of rehospitalization. This study provides evidence that IOT could prevent rehospitalization of schizophrenia patients.
Keywords: follow-up; occupational therapy; randomized controlled trial; rehospitalization; schizophrenia.
Copyright © 2025, Shimada et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Japanese Association of Occupational Therapists issued approval 2020001. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This study was supported by the Japanese Association of Occupational Therapists (grant number: 2020001) and JSPS KAKENHI (grant number: JP 24K02671). Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures



Similar articles
-
Effect of adding individualized occupational therapy to standard care on rehospitalization of patients with schizophrenia: A 2-year prospective cohort study.Psychiatry Clin Neurosci. 2019 Aug;73(8):476-485. doi: 10.1111/pcn.12858. Epub 2019 Jun 13. Psychiatry Clin Neurosci. 2019. PMID: 31077519 Clinical Trial.
-
A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.PLoS One. 2018 Apr 5;13(4):e0193869. doi: 10.1371/journal.pone.0193869. eCollection 2018. PLoS One. 2018. PMID: 29621261 Free PMC article. Clinical Trial.
-
Effect of individualized occupational therapy on social functioning in patients with schizophrenia: A five-year follow-up of a randomized controlled trial.J Psychiatr Res. 2022 Dec;156:476-484. doi: 10.1016/j.jpsychires.2022.10.066. Epub 2022 Nov 1. J Psychiatr Res. 2022. PMID: 36347107 Clinical Trial.
-
Prevention of suicide and attempted suicide in Denmark. Epidemiological studies of suicide and intervention studies in selected risk groups.Dan Med Bull. 2007 Nov;54(4):306-69. Dan Med Bull. 2007. PMID: 18208680 Review.
-
Electroconvulsive therapy for treatment-resistant schizophrenia.Cochrane Database Syst Rev. 2019 Mar 19;3(3):CD011847. doi: 10.1002/14651858.CD011847.pub2. Cochrane Database Syst Rev. 2019. PMID: 30888709 Free PMC article.
References
-
- Maintenance treatment with antipsychotic drugs for schizophrenia. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM. Cochrane Database Syst Rev. 2012:0. - PubMed
-
- Improving patient outcomes in schizophrenia: achieving remission, preventing relapse, and measuring success. Kane JM. J Clin Psychiatry. 2013;74:0. - PubMed
-
- [Current status and issues of early occupational therapy intervention for persons with mental disorders: a scoping review of case reports and interventional studies in Japan] Sasaki T, Tanimura A. JOTR. 2023;42:34–42.
-
- Development of an individualized occupational therapy programme and its effects on the neurocognition, symptoms and social functioning of patients with schizophrenia. Shimada T, Nishi A, Yoshida T, Tanaka S, Kobayashi M. Occup Ther Int. 2016;23:425–435. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous